ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2246

Rheumatoid Arthritis Patient Discordance with Provider Treatment Goals Is Associated with Poorer RA Outcomes

Kelly O'Neill1, Pamela Sinicrope2, Cynthia Crowson3, Kathryne Marks4, Rachel Giblon5, Elena Myasoedova2 and John Davis2, 1Rheumatoid Patient Foundation, Winter Springs, FL, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Eyota, MN, 4Brigham and Women's Hospital, Boston, MA, 5Mayo Clinic, Rochester, MN, Rochester, MN

Meeting: ACR Convergence 2022

Keywords: Outcome measures, Patient reported outcomes, Qualitative Research, Reactive arthritis, Surveys

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Patient Outcomes, Preferences, and Attitudes: Patient Priorities and Preferences: Interventions and Transformation

Session Type: Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: We previously reported on themes in rheumatoid arthritis (RA) patients’ treatment goals which associated with aspects of rheumatology care such as presence of a treatment plan or shared goal discussion as well as disease activity (DA) levels. Building on our previous reports, we aimed to gain insight to the nature of the discordance between patient and provider goals and their association to outcomes.

Methods: An anonymous online questionnaire was presented in 2019 on a secure survey system. U.S. residents ≥18 years of age with a self-reported RA diagnosis by a medical professional responded to questions on demographics, DA, DMARD history, improvement from treatment, and RA treatment goals. Participants were asked how their providers’ RA treatment goals differed from their own. Responses were assessed and coded thematically by a team using qualitative content analysis to identify reasons their goals differed from their providers’. Responses were also coded for strong emotion, poor communication, and difference in outcome expectation (high or low). Relationships between patient outcomes and discordance with provider treatment goals were assessed using Chi-square tests for categorical variables and Kruskal-Wallis tests for continuous variables.

Results: The survey was completed by 907 RA patients (90% women) with 58 (11) yrs mean (SD) age and 11 (10) yrs since diagnosis. 82% (n=740) responded to the question “How do you think your healthcare provider’s treatment goals differ from your own goals?”. Of those, 53% (n=392) did not differ (“aligned” with their providers’ goals). Self-reported DA was moderate to severe in 67% of respondents whose goals were aligned compared to 81% among those non-aligned, with self-assessed remission rates of 7% and 2%, respectively (p=< 0.001). Provider diagnosed remission and self-reported treatment improvement of 50% or more was also higher among aligned respondents than non-aligned; 14% vs 9%, p=0.034 and 77% vs 61%, p< 0.001, respectively. Additionally, aligned responders were more likely to be in good to very good health (47% vs 33%, p< 0.001).

Conclusion: This survey explored patient discordance with providers’ treatment goals and how that discordance associates with treatment outcomes like remission, improvement from treatment, and current level of DA. Further research should seek greater insight to RA patient treatment goals and discordance with providers’ goals to explore their significance in RA outcomes.

Supporting image 1

RA treatment outcomes by whether or not patients align with providers’ treatment goals.

Supporting image 2

Levels of symptom improvement with treatment are divided by those who considered their goals aligned with their provider’s vs those who did not consider their goals aligned. Greater symptom improvement is more associated with aligned goals while lower symptom improvement is associated with not aligned goals.

Supporting image 3

Those who considered their goals aligned with their provider’s and those who did not consider their goals aligned are divided by those who have been diagnosed as being in remission vs not. Respondents in the aligned category were more likely to have been diagnosed with remission.


Disclosures: K. O'Neill, None; P. Sinicrope, None; C. Crowson, None; K. Marks, None; R. Giblon, None; E. Myasoedova, None; J. Davis, Pfizer.

To cite this abstract in AMA style:

O'Neill K, Sinicrope P, Crowson C, Marks K, Giblon R, Myasoedova E, Davis J. Rheumatoid Arthritis Patient Discordance with Provider Treatment Goals Is Associated with Poorer RA Outcomes [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-patient-discordance-with-provider-treatment-goals-is-associated-with-poorer-ra-outcomes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patient-discordance-with-provider-treatment-goals-is-associated-with-poorer-ra-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology